amin semaglutide Efficacy and safety of in patients with heart failure with preserved ejection fraction and obesity - Rehman - 2024 - Clinical Cardiology amin semaglutide Dr Tom Talk:

Since 2021, GLP-1 medications have been utilized in different forms to aid obese patients (BMI 30) and overweight patients (BMI 27) with at least one weight-related condition, such as high blood pressure, type II diabetes, or high cholesterol

Here's what you can expect: Semaglutide mimics a hormone that helps regulate blood sugar, reduces appetite, and slows digestion

Mechanistically, these effects are linked to GLP-1 RA-mediated suppression of inflammatory pathways, modulation of skeletal muscle metabolism, and preservation of mitochondrial function, thereby influencing insulin resistance

Codeage GLP-1 Probiotic+ harnesses the benefits of beneficial bacteria to support gut health

Discover the latest clinical evidence on treatment duration, maintenance strategies, and how PlexusDx helps you find your sustainable weight loss protocol starting at just $149 per month

Employers who prioritize cardiometabolic health as a business strategy will find that GLP-1s are a key piece of a larger puzzle.